52 related articles for article (PubMed ID: 9635914)
1. Prevalence, Risk Factors, and Molecular Detection of
Hoque N; Islam SKS; Uddin MN; Arif M; Haque AKMZ; Neogi SB; Hossain MM; Yamasaki S; Kabir SML
Pathogens; 2021 Mar; 10(3):. PubMed ID: 33800065
[TBL] [Abstract][Full Text] [Related]
2. Dairy Cattle, a Potential Reservoir of Human Campylobacteriosis: Epidemiological and Molecular Characterization of
An JU; Ho H; Kim J; Kim WH; Kim J; Lee S; Mun SH; Guk JH; Hong S; Cho S
Front Microbiol; 2018; 9():3136. PubMed ID: 30619204
[No Abstract] [Full Text] [Related]
3. Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosa.
Han S; Zaniewski RP; Marr ES; Lacey BM; Tomaras AP; Evdokimov A; Miller JR; Shanmugasundaram V
Proc Natl Acad Sci U S A; 2010 Dec; 107(51):22002-7. PubMed ID: 21135211
[TBL] [Abstract][Full Text] [Related]
4. Extended-spectrum-beta-lactamase, AmpC, and Carbapenemase issues.
Thomson KS
J Clin Microbiol; 2010 Apr; 48(4):1019-25. PubMed ID: 20181902
[No Abstract] [Full Text] [Related]
5. Inhibition of class A beta-lactamases by carbapenems: crystallographic observation of two conformations of meropenem in SHV-1.
Nukaga M; Bethel CR; Thomson JM; Hujer AM; Distler A; Anderson VE; Knox JR; Bonomo RA
J Am Chem Soc; 2008 Sep; 130(38):12656-62. PubMed ID: 18761444
[TBL] [Abstract][Full Text] [Related]
6. Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals.
Mulvey MR; Bryce E; Boyd D; Ofner-Agostini M; Christianson S; Simor AE; Paton S;
Antimicrob Agents Chemother; 2004 Apr; 48(4):1204-14. PubMed ID: 15047521
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia.
Livermore DM; Carter MW; Bagel S; Wiedemann B; Baquero F; Loza E; Endtz HP; van Den Braak N; Fernandes CJ; Fernandes L; Frimodt-Moller N; Rasmussen LS; Giamarellou H; Giamarellos-Bourboulis E; Jarlier V; Nguyen J; Nord CE; Struelens MJ; Nonhoff C; Turnidge J; Bell J; Zbinden R; Pfister S; Mixson L; Shungu DL
Antimicrob Agents Chemother; 2001 Jun; 45(6):1860-7. PubMed ID: 11353638
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo activities of amikacin, cefepime, amikacin plus cefepime, and imipenem against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
Szabó D; Máthé A; Filetóth Z; Anderlik P; Rókusz L; Rozgonyi F
Antimicrob Agents Chemother; 2001 Apr; 45(4):1287-91. PubMed ID: 11257049
[TBL] [Abstract][Full Text] [Related]
9. Extended-spectrum plasmid-mediated beta-lactamases.
Sirot D
J Antimicrob Chemother; 1995 Jul; 36 Suppl A():19-34. PubMed ID: 8543494
[TBL] [Abstract][Full Text] [Related]
10. Clinical strategies for serious infection: a North American perspective.
Quinn JP
Diagn Microbiol Infect Dis; 1998 Jun; 31(2):389-95. PubMed ID: 9635914
[TBL] [Abstract][Full Text] [Related]
11. Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms.
Sharma R; Park TE; Moy S
Clin Ther; 2016 Mar; 38(3):431-44. PubMed ID: 26948862
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group.
Jones RN; Pfaller MA; Doern GV; Erwin ME; Hollis RJ
Diagn Microbiol Infect Dis; 1998 Mar; 30(3):215-28. PubMed ID: 9572029
[TBL] [Abstract][Full Text] [Related]
13. Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE).
Pfaller MA; Jones RN; Marshall SA; Coffman SL; Hollis RJ; Edmond MB; Wenzel RP
Diagn Microbiol Infect Dis; 1997 Aug; 28(4):211-9. PubMed ID: 9327251
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility and beta-lactamase production of selected gram-negative bacilli from two Croatian hospitals: MYSTIC study results.
Bedenic B; Goic-Barisic I; Budimir A; Tonkic M; Mihajkevic LJ; Novak A; Sviben M; Plecko V; Punda-Polic V; Kalenic S
J Chemother; 2010 Jun; 22(3):147-52. PubMed ID: 20566417
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
